
Nobixon-SB 1.5 Injection
Marketer
Noble Bio Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Nobixon-SB 1.5 Injection
Combix-1.5 Injection is a dual-action medication used to combat diverse bacterial infections. Its mechanism targets microorganisms, inhibiting their proliferation and halting infection spread. Administration of Combix-1.5 Injection must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement. Premature cessation may compromise the drug's efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Any worsening side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions (e.g., skin rashes, itching, edema, respiratory distress). Inform your physician of all current medications before initiating treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Ample rest, a nutritious diet, and adequate hydration are recommended for optimal recovery. Your doctor might order lab tests and diagnostics to monitor the medication's effects.
Primary Ingredients of Nobixon-SB 1.5 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Nobixon-SB 1.5 Injection
Infections caused by bacteria
Major Benefits of Nobixon-SB 1.5 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Nobixon-SB 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Nobixon-SB 1.5 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Nobixon-SB 1.5 Injection works:
Ceftriaxone and Sulbactam, the components of Nobixon-SB 1.5 Injection, act synergistically to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thereby inhibiting bacterial growth. Sulbactam, a beta-lactamase inhibitor, safeguards Ceftriaxone's efficacy by neutralizing bacterial enzymes that would otherwise degrade it.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant alcohol and Nobixon-SB 1.5 Injection use.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Nobixon-SB 1.5 Injection is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; however, data from human trials are scarce.
Breast feedingCAUTION
The administration of Nobixon-SB 1.5 Injection to breastfeeding mothers requires careful consideration. It is recommended to discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Nobixon-SB 1.5 Injection could lead to drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is inadvisable if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Nobixon-SB 1.5 Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Nobixon-SB 1.5 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Nobixon-SB 1.5 Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Nobixon-SB 1.5 Injection :
Omitting a scheduled dose of Nobixon-SB 1.5 Injection warrants immediate physician consultation.
Facts to Know About Nobixon-SB 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
